Laura A. Martínez-Martínez

Dr. Laura A. Martínez-Martínez

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2012 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
GVGilberto Vargas-Alarcón
Gilberto Vargas-Alarcón
EAEdith Alvarez-Leon
Edith Alvarez-Leon
JFJosé Manuel Fragoso
José Manuel Fragoso
AVAngelica Vargas
Angelica Vargas
LMLaura A. Martínez-Martínez
Laura A. Martínez-Martínez
MMManuel Martínez-Lavín
Manuel Martínez-Lavín
Background: A consistent line of investigation suggests that autonomic nervous system dysfunction may explain the multi-system features of fibromyalgia (FM); and that FM is a sympathetically maintained neuropathic pain syndrome. Dorsal root ganglia (DRG) are key sympathetic-nociceptive short-circuit sites. Sodium channels located in DRG (particularly Nav1.7) act as molecular gatekeepers for pain detection. Nav1.7 is encoded in gene SCN9A of chromosome 2q24.3 and is predominantly expressed in the DRG pain-sensing neurons and sympathetic ganglia neurons. Several SCN9A sodium channelopathies have been recognized as the cause of rare painful dysautonomic syndromes such as paroxysmal extreme pain disorder and primary erythromelalgia. The aim of this study was to search for an association between fibromyalgia and several SCN9A sodium channels gene polymorphisms. Methods: We studied 73 Mexican women suffering from FM and 48 age-matched women who considered themselves healthy. All participants filled out the Fibromyalgia Impact Questionnaire (FIQ). Genomic DNA from whole blood containing EDTA was extracted by standard techniques. The following SCN9A single-nucleotide polymorphisms (SNP) were determined by 5' exonuclease TaqMan assays: rs4371369; rs4387806; rs4453709; rs4597545; rs6746030; rs6754031; rs7607967; rs12620053; rs12994338; and rs13017637. Results: The frequency of the rs6754031 polymorphism was significantly different in both groups (P = 0.036) mostly due to an absence of the GG genotype in controls. Interestingly; patients with this rs6754031 GG genotype had higher FIQ scores (median = 80; percentile 25/75 = 69/88) than patients with the GT genotype (median = 63; percentile 25/75 = 58/73; P = 0.002) and the TT genotype (median = 71; percentile 25/75 = 64/77; P = 0.001). Conclusion: In this ethnic group; a disabling form of FM is associated to a particular SCN9A sodium channel gene variant. These preliminary results raise the possibility that some patients with severe FM may have a dorsal root ganglia sodium channelopathy.

16 November 2011 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
Claudia LermaClaudia Lerma
Claudia Lerma
LMLaura A. Martínez-Martínez
Laura A. Martínez-Martínez
NRNatllely Ruiz
Natllely Ruiz
AVAngelica Vargas
Angelica Vargas
ÓIÓscar Infante
Óscar Infante
MMManuel Martinez-Lavin
Manuel Martinez-Lavin
Introduction: At present, there is neither a laboratory test nor an imaging technique able to differentiate people with fibromyalgia (FM) from healthy controls. This lack of an objective biomarker has hampered FM recognition and research. Heart rate variability (HRV) analyses provide a quantitative marker of autonomic nervous system activity. Nighttime is a stable period in which most people are resting. Sleep is modulated by autonomic activity. Sleeping problems are prominent in FM. The objectives of this study are: 1) to explore different nocturnal HRV parameters as potential FM biomarkers and 2) to seek correlation between such HRV parameters and diverse FM symptoms. Methods: We studied 22 women suffering from FM and 22 age-matched controls. All participants filled out several questionnaires related to FM symptoms. All participants used a Holter monitor over 24 hours while undertaking their routine activities during the day and while sleeping at their homes at night. Time-domain HRV parameters analyzed from 0000 to 0600 hours included, among others: mean normal-normal interbeat intervals (mean NN), standard deviation of the NN intervals (SDNN), and standard deviation of the successive NN differences (SDSD). Results: Nocturnal SDNN of less than 114 ms had the greatest predictive value to set apart patients from controls with an odds ratio of 13.6 (95% confidence interval: 3.9 to 47.8). In patients, decreased nighttime HRV markers indicative of sympathetic predominance had significant correlations with several FM symptoms: SDSD was associated with pain intensity (r = - 0.65, P = 0.001). SDNN correlated with constipation (r = - 0.53, P = 0.001), and mean NN with depression (r = - 0.53, P = 0.001). Controls displayed an opposite behavior. For them, increased nighttime SDNN correlated with Fibromyalgia Impact Questionnaire scores (r = 0.69, P = 0.001) and with other FM symptoms. Conclusions: Nocturnal HRV indices indicative of sympathetic predominance are significantly different in FM women when compared to healthy individuals. In FM patients, these HRV parameters correlated with several symptoms including pain severity. Opposite associations were seen in controls. FM may not be just one end of a continuous spectrum of common symptoms. Nocturnal HRV analyses are potential FM biomarkers.

2 December 2020 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
ABAna-Beatriz Batres-Marroquín
Ana-Beatriz Batres-Marroquín
AMAna-Cristina Medina-García
Ana-Cristina Medina-García
AGAngélica Vargas Guerrero
Angélica Vargas Guerrero
MBMaría-Isabel Barrera-Villalpando
María-Isabel Barrera-Villalpando
MMManuel Martínez-Lavín
Manuel Martínez-Lavín
LMLaura A. Martínez-Martínez
Laura A. Martínez-Martínez

11 November 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
CGCarlos Alfonso Guzmán-Martín
Carlos Alfonso Guzmán-Martín
YJYaneli Juárez-Vicuña
Yaneli Juárez-Vicuña
ADAarón Domínguez-López
Aarón Domínguez-López
JGJavier González-Ramírez
Javier González-Ramírez
LALuis M Amezcua-Guerra
Luis M Amezcua-Guerra
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz

23 April 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
YJYaneli Juárez-Vicuña
Yaneli Juárez-Vicuña
CGCarlos Alfonso Guzmán-Martín
Carlos Alfonso Guzmán-Martín
LMLaura A. Martínez-Martínez
Laura A. Martínez-Martínez
Adrián Hernández-DíazcouderAdrián Hernández-Díazcouder
Adrián Hernández-Díazcouder
CHClaudia Huesca-Gómez
Claudia Huesca-Gómez
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz

22 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMario Peña Peña
Mario Peña Peña
JGJavier González-Ramírez
Javier González-Ramírez
EBElyzabeth Bermúdez-Benítez
Elyzabeth Bermúdez-Benítez
JRJose Luis Rush
Jose Luis Rush
LALuis M Amezcua-Guerra
Luis M Amezcua-Guerra
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz
Background/Objectives: RA is a chronic autoimmune disease characterized by systemic inflammation and progressive joint damage. Plant-based dietary interventions have recently emerged as complementary anti-inflammatory therapy for active RA. However, the molecular anti-inflammatory mechanisms of plant-based dietary patterns in these patients are still poorly understood. Long non-coding RNAs (lncRNAs) have emerged as key regulators of inflammation in chronic diseases. Thus, this study aimed to evaluate the expression of lncRNAs and inflammatory genes in relation to the clinical response to following a plant-based dietary intervention in patients with active RA. Methods: A two-phase whole-blood gene expression analysis was conducted for patients with active RA before and after a 14-day plant-based dietary intervention. In the discovery phase, seven patients showing the greatest reduction in disease activity (DAS28-CRP) were selected, and the expression of 84 inflammatory genes and 84 lncRNAs was analyzed using RT2 Profiler PCR Array platforms. In the validation phase, by adding 14 patients, we assessed 21 participants. Results: NUTM2A-AS1 was the only significantly overexpressed lncRNA in the discovery phase (p = 0.0435), while CCR3 was the only inflammatory gene showing significant expression change (p = 0.0156). In the validation phase, both NUTM2A-AS1 and CCR3 maintained the same pattern of overexpression, confirming their modulation after the 14-day plant-based dietary intervention (p = 0.0131 and p < 0.001, respectively). Conclusions: This study showed that a 14-day plant-based diet was sufficient to modify the inflammatory circuits in patients with active RA, suggesting a potential dietary-mediated inflammatory modulation mechanism involving NUTM2A-AS1 and CCR3. Further studies are required to validate new hypotheses on the biological significance of the regulation of these transcripts and its clinical implications in RA management.